Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Miele Cosmed GroupWAR:DMG 70 Return-on-Tangible-Equity is 10.74% as of Mar. 2026, which is 16% above its 10-year median of 9.28. GuruFocus rates WAR:DMG with a GF Score™ of 70/100 and a GF Value™ of zł3.86 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,881 Consumer Packaged Goods companies, Dr Miele Cosmed Group ranks better than 61.24% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Dr Miele Cosmed Group's annualized net income for the quarter that ended in Mar. 2026 was zł15.9 Mil. Dr Miele Cosmed Group's average shareholder tangible equity for the quarter that ended in Mar. 2026 was zł148.4 Mil. Therefore, Dr Miele Cosmed Group's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 10.74%.
The historical rank and industry rank for Dr Miele Cosmed Group's Return-on-Tangible-Equity or its related term are showing as below:
WAR:DMG'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -116.37 Med: 9.28 Max: 38.62
Current: 11.29
During the past 13 years, Dr Miele Cosmed Group's highest Return-on-Tangible-Equity was 38.62%. The lowest was -116.37%. And the median was 9.28%.
WAR:DMG's Return-on-Tangible-Equity is ranked better than 61.24% of 1881
companies
in the Consumer Packaged Goods industry
Industry Median: 7.78
vs WAR:DMG: 11.29
Dr Miele Cosmed Group (WAR:DMG) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Dr Miele Cosmed Group Return-on-Tangible-Equity Related Terms
Dr Miele Cosmed Group Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Dr Miele Cosmed Group's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Miele Cosmed Group Return-on-Tangible-Equity Chart
WAR:DMG vs PG, CL, KVUE: Return-on-Tangible-Equity Comparison
For the Household & Personal Products subindustry, Dr Miele Cosmed Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Miele Cosmed Group Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dr Miele Cosmed Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Dr Miele Cosmed Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 10.74% mean?
Dr Miele Cosmed Group (WAR:DMG) has a Return-on-Tangible-Equity of 10.74% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dr Miele Cosmed Group and its competitors. This is 16% above median its historical median of 9.28. According to the industry distribution chart, Dr Miele Cosmed Group ranks #729 out of 1881 companies in the Consumer Packaged Goods industry, placing it in the top 38.8%.
Is Dr Miele Cosmed Group's Return-on-Tangible-Equity too high?
Dr Miele Cosmed Group's current Return-on-Tangible-Equity of 10.74% is 16% above median its 10-year median of 9.28. The Consumer Packaged Goods industry median Return-on-Tangible-Equity is 7.78. Dr Miele Cosmed Group's value of 10.74% is 38% above this industry median. Based on the distribution chart, Dr Miele Cosmed Group ranks #729 out of 1881 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Dr Miele Cosmed Group has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Miele Cosmed Group's Return-on-Tangible-Equity compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Dr Miele Cosmed Group ranks #729 out of 1881 companies for Return-on-Tangible-Equity. This puts Dr Miele Cosmed Group in the upper half of its industry. The industry median Return-on-Tangible-Equity is 7.78. Dr Miele Cosmed Group's value of 10.74% is 38% above this benchmark. While the company's 10-year median is 9.28 vs. the industry median of 7.78, Dr Miele Cosmed Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.78, based on 1,881 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Miele Cosmed Group's current Return-on-Tangible-Equity of 10.74% is 38% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dr Miele Cosmed Group and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Miele Cosmed Group's current Return-on-Tangible-Equity is 10.74%, which is 16% above median its own 10-year median of 9.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Miele Cosmed Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Miele Cosmed Group (WAR:DMG) is currently considered Significantly Undervalued. The stock's GF Value™ is zł3.86, compared to a current price of zł2.39 — trading 38.1% below its estimated fair value. The current Return-on-Tangible-Equity is 10.74%, which is 16% above median its 10-year median of 9.28 and 38% above the Consumer Packaged Goods industry median of 7.78. Dr Miele Cosmed Group's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Dr Miele Cosmed Group (WAR:DMG), the current Return-on-Tangible-Equity is 10.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Miele Cosmed Group (WAR:DMG) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Miele Cosmed Group stock appears to be undervalued.
The current stock price of zł2.39 is trading 38.1% below its estimated GF Value™ of zł3.86.
GuruFocus considers Dr Miele Cosmed Group to be Significantly Undervalued.
Key valuation signals for WAR:DMG:
Return-on-Tangible-Equity: 10.74% (16% above median its 10-year median of 9.28)
GF Value™: zł3.86 vs. price of zł2.39 (38.1% below fair value)
Industry Position: 38% above the Consumer Packaged Goods median (#729 of 1881)
No single metric tells the full story. See the WAR:DMG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Miele Cosmed Group SA is engaged in manufacturing cosmetics and household chemicals for national and international retailers, fulfils consumer needs in the sector of personal care, hygiene and cleanliness. The company's brands include Apart, Biophen, Mole, Bobini, Sofin and Izo.
70GF Score
Get the complete analysis for WAR:DMG
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:DMG has been successfully added to your 
